Exercise Program for Prostate Cancer
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine whether a 16-week supervised, clinic-based circuit training intervention utilizing resistance and functional exercises and self-directed aerobic exercise will improve frailty and sarcopenic status and disease progression outcomes among pre-frail/frail metastatic prostate cancer patients receiving androgen deprivation therapy (ADT). The names of the study intervention involved in this study is: • Supervised circuit training (aerobic and resistance exercise regimen)
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be on androgen deprivation therapy and cannot be receiving chemotherapy or treatment for other active cancers, except for basal cell carcinoma.
What data supports the effectiveness of the treatment Supervised Circuit Training, Exercise Therapy, Physical Therapy, Rehabilitation Exercise for prostate cancer?
Research shows that exercise, including resistance and endurance training, can improve quality of life, muscle strength, and cardiovascular health in prostate cancer patients, especially those undergoing androgen-deprivation therapy. These exercises help manage treatment side effects like muscle loss and depression, and may also slow disease progression.12345
Is exercise safe for prostate cancer patients?
How is the Supervised Circuit Training treatment for prostate cancer different from other treatments?
Supervised Circuit Training is unique because it focuses on improving physical function and quality of life through a combination of endurance and resistance exercises, even for prostate cancer patients with bone metastases, who are often excluded from exercise programs due to fracture risks. This approach helps counteract muscle loss and functional impairments caused by androgen deprivation therapy and other cancer treatments.2691011
Research Team
Christina M Dieli-Conwright, PhD
Principal Investigator
Dana-Farber Cancer Institute
Eligibility Criteria
The FIERCE Trial is for English-speaking men over 18 with metastatic prostate cancer who are pre-frail or frail and on ADT. They must be willing to travel to Dana-Farber Cancer Institute, have physician clearance for exercise, and not already doing much structured exercise.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants partake in a 16-week supervised exercise program or continue with normal activities
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Supervised Circuit Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
Prostate Cancer Foundation
Collaborator